William DeVaul
General Counsel at MORPHIC HOLDING, INC.
Net worth: 644 351 $ as of 2024-04-29
William DeVaul active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MORPHIC HOLDING, INC. | General Counsel | 2019-01-31 | - |
| Corporate Secretary | 2019-01-31 | - | |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | General Counsel | - | - |
| Corporate Secretary | - | - |
Career history of William DeVaul
Former positions of William DeVaul
| Companies | Position | Start | End |
|---|---|---|---|
| EVELO BIOSCIENCES, INC. | Corporate Officer/Principal | 2015-04-30 | 2019-01-31 |
| CUBIST PHARMACEUTICALS INC | Corporate Officer/Principal | 2002-12-31 | 2015-01-31 |
Training of William DeVaul
| Boston University School of Law | Graduate Degree |
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
Statistics
International
| United States | 7 |
Operational
| Corporate Officer/Principal | 2 |
| General Counsel | 2 |
| Corporate Secretary | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| EVELO BIOSCIENCES, INC. | Health Technology |
| MORPHIC HOLDING, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
- Stock Market
- Insiders
- William DeVaul
- Experience
